Publications
Search our bibliography using the filters on the right-hand side.
Displaying 1 through 50 of 453 publications.
Skip to main content
Cocas LA, Miyoshi G, Carney RSE, Sousa VH, Hirata T, Jones KR, Fishell G, Huntsman MM, Corbin JG. Emx1-lineage progenitors differentially contribute to neural diversity in the striatum and amygdala. J Neurosci. 2009 Dec 16;29(50):15933-46. doi: 10.1523/JNEUROSCI.2525-09.2009
Anderson IM, Jones S, Twiss J. Do negative cognitive style and personality predict depression symptoms and functional outcomes in severe bipolar and unipolar disorders? Int J Cogn Ther. 2009 Dec 15;2(4):343-53. doi: 10.1521/ijct.2009.2.4.343
Sherrill B, Amonkar M, Sherif B, Maltzman J, O'Rourke L, Johnston S. An exploration of the association of qol scores with tumor progression status in first-line hr+, her2+ mbc patients treated with lapatinib plus letrozole or letrozole alone. Poster presented at the 32nd San Antoniio Breast Cancer Symposium Annual Meeting; December 14, 2009.
Hoerger TJ, Zhang P, Segel JE, Gregg EW, Venkat Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract. 2009 Dec 1;86(3):225-32.
Sherrill B, Amonkar MM, Sherif BN, Maltzman J, O'Rourke L, Johnston S. An exploration of the association of Quality-of-Life (QOL) scores with tumor progression status in first line hormone receptor positive, HER2+ Metastatic Breast Cancer (MBC) patients treated with lapatinib plus letrozole or letrozole alone. Poster presented at the Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium; December 2009. San Antonio, TX. [abstract] Cancer Res. 2009 Dec; 69(24 (Suppl)):5106. doi: 10.1158/0008-5472.SABCS-09-5106
Van Houtven G, Poulos C. Valuing welfare impacts of beach erosion: an application of the structural benefit transfer method. Am J Agric Econ. 2009 Dec 1;91(5):1343-50.
Hoyo C, Schildkraut JM, Murphy SK, Chow WH, Vaughan TL, Risch H, Marks JR, Jirtle RL, Calingaert B, Mayne S, Fraumeni, Jr. J, Gammon MD. IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. Int J Cancer. 2009 Dec 1;125(11):2673-8.
Johannes CB, Clayton AH, Odom DM, Rosen RC, Russo PA, Shifren JL, Monz BU. Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry. 2009 Dec 1;70(12):1698-706.
Castellsague J, Holick CN, Hoffman CC, Gimeno V, Stang MR, Perez-Gutthann S. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs. Pharmacotherapy. 2009 Dec;29(12):1397-407. doi: 10.1592/phco.29.12.1397
Debanjali M, Hodgkins P, Yen L, Solomon D, Davis KL, Cohen R. Adherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis: impact on all-cause healthcare costs. Inflamm Bowel Dis. 2009 Dec 1;15(12):S32.
Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome foundation report. Gastroenterology. 2009 Dec 1;137(6):1944-53.
Chatzi L, Plana E, Pappas A, Alegkakis D, Karakosta P, Daraki V. The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus. Diabetes Metab. 2009 Dec;35(6):490-4.
Candrilli SD, O'Brien SH, Ware RE, Nahata MC, Seiber EE, Balkrishnan R. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Poster presented at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition; December 5, 2009. New Orleans, LA. [abstract] Blood. 2009 Nov 20; 114(22):2483. doi: 10.1182/blood.V114.22.2483.2483
Wolowacz S. The United Kingdom's national institute for health and clinical excellence: new developments. Poster presented at the 2009 ISPOR 12th Annual European Congress; November 19, 2009.
Zarkin GA, Cowell AJ, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Benefits and costs of alternative substance abuse treatment programs for individuals in state prisons: results from a lifetime simulation model. Presented at the American Society of Criminology Annual Meeting; November 2009. Previously presented at the Addiction Health Services Research Annual conference.
Cowell AJ, Zarkin GA, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Findings on drug use, crime, arrests, and other model outcomes from a simulation model of prison-based substance abuse treatment. Presented at the American Society of Criminology Annual Meeting; November 2009.
Ferreira-Gonzalez I, Marsal JR, Mitjavila F, Parada A, Ribera A, Cascant P, Soriano N, Sanchez PL, Aros F, Heras M, Bueno H, Marrugat J, Cunat J, Civeira E, Permanyer-Miralda G. Patient registries of acute coronary syndrome: assessing or biasing the clinical real world data? Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):540-7. doi: 10.1161/CIRCOUTCOMES.108.844399
Talbird SE, Brogan AJ, Winiarski AP. Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S. Am J Prev Med. 2009 Nov 1;37(5):381-8.
Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother. 2009 Nov 1;10(16):2581-92. doi: 10.1517/14656560903304063.
Oglesby A, Sherif B, Odom D, Leahy M, Qian Y. Time and costs associated with preparing and administering zoledronic acid in patients with breast or prostate cancer and metastatic bone disease. Community Oncol. 2009 Nov 1;6(11):494-502.
Foster T, Brown TM, Chang J, Menssen HD, Blieden MB, Herzog TJ. A review of the current evidence for maintenance therapy in ovarian cancer. Gynecol Oncol. 2009 Nov 1;115:290-301.
Mast TC, Zhu XS, Demuro-Mercon C, Cummings HW, Sings HL, Ferris DG. Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV. Curr Med Res Opin. 2009 Nov 1;25(11):2609-19.
Jackel J, Davis KL, Patel A. Stroke in the long-term care setting: patient characteristics and medication treatment. Poster presented at the Annual Meeting of the American Society of Consultant Pharmacists; November 2009.
Jackel J, Davis KL, Patel A. TIA in the long-term care setting: patient characteristics and medication treatment. Poster presented at the Annual Meeting of the American Society of Consultant Pharmacists; November 2009.
Foraster M, Medina-Ramon M, Basagana X, Bouso L, Elosua R, Juvinya D, Rivera M, Santos-Garces E, Kuenzli N, Deltell A. Noise and air pollution correlation and its determinants in the city of Girona. Poster presented at the ISEE 21st Annual Conference; August 25, 2009. Dublin, Ireland. [abstract] Epidemiology. 2009 Nov; 20(6):S180. doi: 10.1097/01.ede.0000362213.13362.0d
Eberth B, Watson V, Ryan M, Hughes J, Barnett G. Does one size fit all? Investigating heterogeneity in men's preferences for benign prostatic hyperplasia treatment using mixed logit analysis. Med Decis Making. 2009 Nov;29(6):707-15. doi: 10.1177/0272989X09341754
Varas-Lorenzo C, Castellsaque J, Stang MR, Perez-Gutthann S, Aguado J, Rodriguez LA. The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1016-25.
Sunyer J, Forastiere F, Pekkanen J, Plana E, Kolz M, Pistelli R. Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. Nicotine Tob Res. 2009 Nov;11(11):1347-53.
Fehnel S. Establishing optimal requirements for content validity: a work in progress. Value Health. 2009 Nov 1;12(8):1074.
Hicks KA, Zarkin GA, Dunlap LJ, Cowell AJ, Mills MJ, Keyes VS. A dynamic model for estimating the costs and benefits on prison-based substance abuse treatment. Poster presented at the American Society of Criminology Annual Meeting; November 2009.
Wolowacz S, Jhaveri M, Tangirala K. Cost-utility model to evaluate adjuvant chemotherapy for early breast cancer in the United States. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009.
Dietrich K, Schned A, Fortuny J, Heaney J, Marsit C, Kelsey KT, Karagas MR. Glucocorticoid therapy and risk of bladder cancer. Br J Cancer. 2009 Oct 20;101(8):1316-20. doi: 10.1038/sj.bjc.6605314
Mehta HB, Parikh RC, Sujit SS. Cost-effectiveness analysis of anti-obesity treatments: orlistat, sibutramine and behavioral therapy. Poster presented at the 31st Society of Medical Decision Making Conference; October 19, 2009. Los Angeles, CA.
Ehrenstein V, Rothman KJ, Pedersen L, Hatch EE, Sorensen HT. Pregnancy-associated hypertensive disorders and adult cognitive function among Danish conscripts. Am J Epidemiol. 2009 Oct 15;170(8):1025-31.
Jung T, Scott T, Davies HTO, Bower P, Whalley D, McNally R, Mannion R. Instruments for exploring organizational culture: a review of the literature. Public Adm Rev. 2009 Oct 12;69(6):1087-96.
Sherrill B, Sherif BN, Amonkar M, Wu Y, Maltzman J, O'Rourke L, Johnston S. Quality of life and quality-adjusted survival (Q-TWIST) in patients receiving lapatinib plus letrozole as first-line therapy in hormone receptor positive, her2+ metastatic breast cancer. Poster presented at the Cancer Symposium of the American Society of Clinical Oncology; October 10, 2009.
Zarkin GA, Cowell AJ, Hicks KA, Dunlap LJ, Belenko S, Mills MJ. Benefits and costs of alternative substance abuse treatment programs for individuals in state prisons: results from a lifetime simulation model. Presented at the Addiction Health Services Research Annual conference; October 2009.
Wolowacz S, Samuel M, Brennan VK, Jasso-Mosqueda J, van Gelder I. The cost of illness of atrial fibrillation: a systematic review. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. [abstract] Value Health. 2009 Oct; 12(7):A325.
Curtis B, Hayes C, Fehnel SE, Kolotkin R. Assessing the impact of weight loss among obese individuals with type 2 diabetes mellitus. Poster presented at the 27th Annual Scientific Meeting of the Obesity Society; October 1, 2009.
Wilburn J, McKenna SP, Twiss J. Further developments of the rheumatoid arthritis quality of life scale (RAQoL). Poster presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, Spain. [abstract] Value Health. 2009 Oct; 12(7):A447-8. doi: 10.1016/S1098-3015(10)75215-3
Mitra D, Hodgkins P, Yen L, Solomon D, Davis KL, Cohen RD. The impact of oral 5- ASA adherence on all-cause health care costs among ulcerative colitis patients. Poster presented at the Annual Scientific Meeting and Postgraduate Course of the American College of Gastroenterology; October 2009.
Mitra D, Davis KL, Hodgkins P, Yen L, Solomon D, Cohen RD. Assessing the relationship between adherence and health care costs: evidence from a managed care population with ulcerative colitis. Poster presented at the 31st Annual Meeting of the Society for Medical Decision Making; October 2009.
Odom DM, Bennett L, Irish W, Mladsi DM. Statistical methods to handle incomplete longitudinal patient-reported outcomes data in advanced disease stage trials. Presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France.
Loftis CE, Jackson LM, Spain CJ, Nguyen MT, Price MA. Considerations and benefits in developing and implementing a web-based interviewer basic training program. Poster presented at the 28th annual Southern Association for Public Opinion Research; October 2009.
Twiss J, Doward LC, McKenna SP, Eckert B. Interpreting scores on the multiple sclerosis-specific PRIMUS and U-FIS outcome measures. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A373. doi: 10.1016/S1098-3015(10)74836-1
Twiss J, McKenna SP, Preston E, Meads DM. Can we rely on scores from the dermatology life quality index? Poster presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A460. doi: 10.1016/S1098-3015(10)75277-3
Kauf T, Davis KL, Earnshaw S, Davis EA, Watson ME. Spillover adherence effects of fixed-dose combination HIV therapy. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. [abstract] Value Health. 2009 Oct; 12(7):A430.